Christopher Lowry
Concepts (715)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Serotonin | 63 | 2025 | 297 | 9.830 |
Why?
| | Raphe Nuclei | 41 | 2019 | 112 | 8.720 |
Why?
| | Tryptophan Hydroxylase | 34 | 2022 | 53 | 5.760 |
Why?
| | Mycobacterium | 13 | 2024 | 102 | 5.140 |
Why?
| | Anxiety | 47 | 2026 | 1125 | 4.760 |
Why?
| | Mycobacteriaceae | 16 | 2026 | 42 | 4.710 |
Why?
| | Serotonergic Neurons | 17 | 2025 | 29 | 4.460 |
Why?
| | Stress, Psychological | 38 | 2026 | 1171 | 4.370 |
Why?
| | Dorsal Raphe Nucleus | 15 | 2025 | 31 | 3.470 |
Why?
| | Proto-Oncogene Proteins c-fos | 24 | 2025 | 193 | 3.210 |
Why?
| | Rats | 85 | 2026 | 5586 | 3.150 |
Why?
| | Behavior, Animal | 28 | 2026 | 531 | 3.130 |
Why?
| | Amygdala | 21 | 2022 | 194 | 3.120 |
Why?
| | Corticotropin-Releasing Hormone | 18 | 2018 | 72 | 3.110 |
Why?
| | Neurons | 44 | 2022 | 1668 | 3.030 |
Why?
| | Gastrointestinal Microbiome | 21 | 2025 | 769 | 2.970 |
Why?
| | Corticosterone | 25 | 2025 | 241 | 2.930 |
Why?
| | Fear | 16 | 2023 | 373 | 2.920 |
Why?
| | Microbiota | 17 | 2025 | 725 | 2.860 |
Why?
| | Animals | 180 | 2026 | 38107 | 2.370 |
Why?
| | Stress Disorders, Post-Traumatic | 15 | 2025 | 892 | 2.180 |
Why?
| | Hyperthermia, Induced | 8 | 2024 | 119 | 2.050 |
Why?
| | Receptors, Corticotropin-Releasing Hormone | 9 | 2019 | 30 | 2.040 |
Why?
| | Inflammation | 29 | 2026 | 2919 | 1.970 |
Why?
| | Rats, Sprague-Dawley | 36 | 2026 | 2537 | 1.950 |
Why?
| | Rats, Wistar | 34 | 2020 | 451 | 1.930 |
Why?
| | Microglia | 7 | 2026 | 289 | 1.910 |
Why?
| | Probiotics | 4 | 2025 | 64 | 1.890 |
Why?
| | Anti-Inflammatory Agents | 9 | 2023 | 474 | 1.860 |
Why?
| | Pituitary-Adrenal System | 12 | 2019 | 169 | 1.800 |
Why?
| | Antidepressive Agents | 10 | 2024 | 235 | 1.780 |
Why?
| | Hypothalamo-Hypophyseal System | 13 | 2019 | 204 | 1.770 |
Why?
| | Extinction, Psychological | 4 | 2023 | 93 | 1.730 |
Why?
| | Central Nervous System | 10 | 2022 | 278 | 1.600 |
Why?
| | Anxiety Disorders | 11 | 2021 | 354 | 1.560 |
Why?
| | Organic Cation Transport Proteins | 10 | 2025 | 25 | 1.560 |
Why?
| | Hippocampus | 10 | 2026 | 989 | 1.520 |
Why?
| | Mental Health | 8 | 2024 | 779 | 1.520 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 11 | 2022 | 61 | 1.490 |
Why?
| | Brain | 29 | 2024 | 2991 | 1.470 |
Why?
| | Panic Disorder | 7 | 2017 | 24 | 1.400 |
Why?
| | Fluoxetine | 7 | 2025 | 56 | 1.320 |
Why?
| | Male | 142 | 2026 | 73396 | 1.290 |
Why?
| | Hypothalamus | 7 | 2025 | 161 | 1.250 |
Why?
| | Motor Activity | 12 | 2021 | 704 | 1.250 |
Why?
| | Glucocorticoids | 6 | 2023 | 536 | 1.170 |
Why?
| | RNA, Ribosomal, 16S | 14 | 2025 | 507 | 1.170 |
Why?
| | Bacterial Vaccines | 4 | 2018 | 63 | 1.160 |
Why?
| | Lipopolysaccharides | 6 | 2023 | 861 | 1.100 |
Why?
| | Depression | 14 | 2025 | 1575 | 1.100 |
Why?
| | Analysis of Variance | 23 | 2018 | 1298 | 1.080 |
Why?
| | Citalopram | 2 | 2018 | 33 | 1.060 |
Why?
| | Depressive Disorder | 3 | 2018 | 361 | 1.040 |
Why?
| | Social Isolation | 3 | 2013 | 73 | 1.040 |
Why?
| | Urocortins | 10 | 2019 | 24 | 1.040 |
Why?
| | Neural Pathways | 13 | 2025 | 319 | 1.030 |
Why?
| | Feces | 8 | 2025 | 496 | 1.020 |
Why?
| | Carbolines | 9 | 2015 | 35 | 1.020 |
Why?
| | Vaccines, Inactivated | 3 | 2018 | 71 | 1.010 |
Why?
| | Environment, Controlled | 3 | 2016 | 22 | 1.010 |
Why?
| | Salamandridae | 11 | 2009 | 33 | 0.970 |
Why?
| | Body Temperature Regulation | 7 | 2019 | 106 | 0.970 |
Why?
| | Tryptophan | 9 | 2022 | 184 | 0.960 |
Why?
| | Mood Disorders | 3 | 2013 | 130 | 0.950 |
Why?
| | Dysbiosis | 2 | 2018 | 184 | 0.930 |
Why?
| | Immunomodulation | 3 | 2016 | 98 | 0.920 |
Why?
| | Immunohistochemistry | 20 | 2019 | 1712 | 0.910 |
Why?
| | Social Behavior | 8 | 2025 | 279 | 0.910 |
Why?
| | Cell Count | 14 | 2015 | 315 | 0.900 |
Why?
| | Serotonin Receptor Agonists | 5 | 2017 | 27 | 0.890 |
Why?
| | Anti-Anxiety Agents | 5 | 2023 | 46 | 0.890 |
Why?
| | Disease Models, Animal | 20 | 2023 | 4580 | 0.880 |
Why?
| | Panic | 4 | 2017 | 8 | 0.850 |
Why?
| | Diet, Western | 1 | 2024 | 89 | 0.820 |
Why?
| | Stress, Physiological | 11 | 2014 | 450 | 0.810 |
Why?
| | RNA, Messenger | 9 | 2020 | 2791 | 0.810 |
Why?
| | Veterans | 9 | 2026 | 1650 | 0.800 |
Why?
| | Toxoplasmosis | 5 | 2025 | 44 | 0.800 |
Why?
| | Dorsomedial Hypothalamic Nucleus | 3 | 2015 | 5 | 0.800 |
Why?
| | Arousal | 6 | 2023 | 158 | 0.780 |
Why?
| | Receptor, Serotonin, 5-HT1A | 8 | 2019 | 37 | 0.770 |
Why?
| | Maternal Deprivation | 4 | 2019 | 16 | 0.750 |
Why?
| | Septal Nuclei | 3 | 2019 | 24 | 0.750 |
Why?
| | Weight Gain | 3 | 2024 | 562 | 0.740 |
Why?
| | Inflammation Mediators | 3 | 2018 | 508 | 0.740 |
Why?
| | Caffeine | 5 | 2018 | 77 | 0.730 |
Why?
| | Immunization | 9 | 2022 | 376 | 0.720 |
Why?
| | Reflex, Startle | 4 | 2019 | 75 | 0.720 |
Why?
| | Mice | 35 | 2026 | 18297 | 0.710 |
Why?
| | Carbon Dioxide | 4 | 2010 | 228 | 0.700 |
Why?
| | Neurons, Afferent | 4 | 2012 | 102 | 0.700 |
Why?
| | Mental Disorders | 9 | 2024 | 1148 | 0.700 |
Why?
| | Cytomegalovirus Infections | 1 | 2023 | 206 | 0.690 |
Why?
| | Toxoplasma | 4 | 2025 | 50 | 0.690 |
Why?
| | Prefrontal Cortex | 3 | 2018 | 339 | 0.680 |
Why?
| | Hydroxyindoleacetic Acid | 11 | 2018 | 24 | 0.670 |
Why?
| | Veterans Health | 2 | 2024 | 188 | 0.670 |
Why?
| | Brain Injuries, Traumatic | 4 | 2020 | 466 | 0.670 |
Why?
| | Hot Temperature | 3 | 2022 | 396 | 0.660 |
Why?
| | Colitis | 4 | 2019 | 283 | 0.620 |
Why?
| | Exploratory Behavior | 5 | 2021 | 86 | 0.620 |
Why?
| | Cerebrospinal Fluid Proteins | 1 | 2020 | 9 | 0.620 |
Why?
| | Proteome | 1 | 2025 | 520 | 0.610 |
Why?
| | Mice, Inbred BALB C | 12 | 2023 | 1244 | 0.610 |
Why?
| | Body Temperature | 5 | 2024 | 228 | 0.610 |
Why?
| | Humans | 99 | 2026 | 146342 | 0.610 |
Why?
| | Environment Design | 2 | 2016 | 26 | 0.600 |
Why?
| | Emotions | 5 | 2023 | 559 | 0.570 |
Why?
| | Interleukin-4 | 1 | 2020 | 207 | 0.570 |
Why?
| | Serotonin Agents | 4 | 2015 | 8 | 0.570 |
Why?
| | Locomotion | 6 | 2021 | 102 | 0.570 |
Why?
| | Brain Concussion | 3 | 2026 | 660 | 0.560 |
Why?
| | Synaptic Transmission | 4 | 2018 | 294 | 0.560 |
Why?
| | Dominance-Subordination | 2 | 2011 | 16 | 0.560 |
Why?
| | Life Style | 3 | 2026 | 496 | 0.560 |
Why?
| | Porphyromonas gingivalis | 3 | 2025 | 23 | 0.550 |
Why?
| | Genes, fos | 2 | 2010 | 26 | 0.540 |
Why?
| | Catecholamines | 3 | 2005 | 88 | 0.530 |
Why?
| | Blood Proteins | 1 | 2020 | 239 | 0.530 |
Why?
| | Interleukin-6 | 5 | 2024 | 784 | 0.530 |
Why?
| | Physical Conditioning, Animal | 2 | 2019 | 243 | 0.530 |
Why?
| | Housing, Animal | 2 | 2016 | 45 | 0.530 |
Why?
| | Behavior | 1 | 2018 | 90 | 0.530 |
Why?
| | Gene Expression Regulation | 9 | 2018 | 2599 | 0.520 |
Why?
| | Swimming | 3 | 2021 | 54 | 0.520 |
Why?
| | 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 2017 | 9 | 0.510 |
Why?
| | Signal Transduction | 5 | 2025 | 5246 | 0.510 |
Why?
| | Proteomics | 2 | 2025 | 1203 | 0.500 |
Why?
| | Hypothermia | 1 | 2017 | 53 | 0.500 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2013 | 902 | 0.500 |
Why?
| | Hypercapnia | 4 | 2012 | 53 | 0.490 |
Why?
| | Gastrointestinal Tract | 1 | 2019 | 203 | 0.490 |
Why?
| | Psychological Trauma | 1 | 2017 | 58 | 0.490 |
Why?
| | Prebiotics | 3 | 2024 | 29 | 0.490 |
Why?
| | Pets | 3 | 2025 | 28 | 0.490 |
Why?
| | Bacteria | 7 | 2025 | 766 | 0.480 |
Why?
| | Vaccination | 3 | 2020 | 1449 | 0.480 |
Why?
| | Military Personnel | 3 | 2019 | 726 | 0.480 |
Why?
| | Parvalbumins | 2 | 2020 | 26 | 0.470 |
Why?
| | Immune System | 2 | 2014 | 181 | 0.470 |
Why?
| | Lipid Metabolism | 1 | 2020 | 533 | 0.460 |
Why?
| | Circadian Rhythm | 4 | 2021 | 515 | 0.460 |
Why?
| | Suicide, Attempted | 4 | 2025 | 391 | 0.450 |
Why?
| | Mice, Inbred C57BL | 14 | 2025 | 6034 | 0.450 |
Why?
| | Organic Anion Transporters, Sodium-Independent | 2 | 2019 | 3 | 0.440 |
Why?
| | Gene Expression | 8 | 2020 | 1463 | 0.430 |
Why?
| | Vasotocin | 4 | 2000 | 5 | 0.430 |
Why?
| | Social Determinants of Health | 1 | 2018 | 317 | 0.410 |
Why?
| | Post-Concussion Syndrome | 1 | 2017 | 185 | 0.410 |
Why?
| | Hormone Replacement Therapy | 1 | 2015 | 107 | 0.400 |
Why?
| | Immobility Response, Tonic | 1 | 2013 | 6 | 0.400 |
Why?
| | Cytokines | 7 | 2023 | 2081 | 0.400 |
Why?
| | Conditioning, Classical | 5 | 2020 | 120 | 0.390 |
Why?
| | Intestines | 2 | 2014 | 351 | 0.390 |
Why?
| | Pons | 2 | 2010 | 33 | 0.380 |
Why?
| | Mesencephalon | 2 | 2010 | 65 | 0.380 |
Why?
| | GABA Antagonists | 6 | 2013 | 35 | 0.370 |
Why?
| | T-Lymphocytes, Regulatory | 3 | 2016 | 415 | 0.370 |
Why?
| | Public Health | 2 | 2022 | 574 | 0.360 |
Why?
| | Sex Characteristics | 2 | 2013 | 801 | 0.360 |
Why?
| | Adaptation, Psychological | 3 | 2014 | 721 | 0.350 |
Why?
| | Prosencephalon | 6 | 2018 | 52 | 0.350 |
Why?
| | Diet, High-Fat | 3 | 2024 | 267 | 0.350 |
Why?
| | Cold Temperature | 1 | 2013 | 208 | 0.350 |
Why?
| | Cushing Syndrome | 1 | 2011 | 10 | 0.350 |
Why?
| | Immunoglobulin G | 5 | 2025 | 901 | 0.350 |
Why?
| | GABAergic Neurons | 1 | 2012 | 38 | 0.340 |
Why?
| | Time Factors | 12 | 2015 | 7109 | 0.340 |
Why?
| | DNA, Bacterial | 3 | 2024 | 319 | 0.340 |
Why?
| | Kynurenine | 5 | 2018 | 114 | 0.340 |
Why?
| | Female | 45 | 2025 | 79499 | 0.340 |
Why?
| | gamma-Aminobutyric Acid | 3 | 2017 | 195 | 0.340 |
Why?
| | Dose-Response Relationship, Drug | 12 | 2015 | 2022 | 0.340 |
Why?
| | Brain Mapping | 5 | 2007 | 541 | 0.340 |
Why?
| | Rats, Long-Evans | 6 | 2021 | 126 | 0.330 |
Why?
| | Suicidal Ideation | 3 | 2025 | 543 | 0.320 |
Why?
| | Aging | 5 | 2024 | 1996 | 0.320 |
Why?
| | Bronchi | 1 | 2012 | 263 | 0.320 |
Why?
| | Socioeconomic Factors | 2 | 2014 | 1327 | 0.320 |
Why?
| | Third Ventricle | 1 | 2010 | 16 | 0.310 |
Why?
| | Light | 3 | 2008 | 401 | 0.310 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2023 | 167 | 0.310 |
Why?
| | Suicide | 4 | 2020 | 647 | 0.300 |
Why?
| | Breast Neoplasms | 1 | 2022 | 2418 | 0.300 |
Why?
| | Animals, Newborn | 5 | 2018 | 888 | 0.290 |
Why?
| | Sequence Analysis, DNA | 2 | 2024 | 771 | 0.290 |
Why?
| | Interneurons | 1 | 2010 | 124 | 0.290 |
Why?
| | Fenfluramine | 1 | 2009 | 20 | 0.290 |
Why?
| | Amish | 2 | 2019 | 7 | 0.280 |
Why?
| | TRPV Cation Channels | 1 | 2008 | 43 | 0.280 |
Why?
| | Antibodies, Protozoan | 4 | 2025 | 41 | 0.280 |
Why?
| | Brain Chemistry | 4 | 2007 | 122 | 0.270 |
Why?
| | Medulla Oblongata | 4 | 2012 | 36 | 0.270 |
Why?
| | Cognition | 4 | 2022 | 1292 | 0.270 |
Why?
| | Sexual Behavior, Animal | 4 | 2006 | 59 | 0.270 |
Why?
| | Chromatography, High Pressure Liquid | 7 | 2018 | 588 | 0.270 |
Why?
| | RNA, Bacterial | 2 | 2020 | 183 | 0.260 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2008 | 127 | 0.260 |
Why?
| | Schizophrenia | 3 | 2016 | 537 | 0.250 |
Why?
| | Encephalitis | 2 | 2020 | 143 | 0.250 |
Why?
| | Pregnancy Trimester, First | 2 | 2025 | 140 | 0.250 |
Why?
| | Sleep Deprivation | 2 | 2020 | 207 | 0.250 |
Why?
| | Relaxin | 2 | 2018 | 18 | 0.250 |
Why?
| | Proto-Oncogene Proteins c-fyn | 1 | 2007 | 11 | 0.250 |
Why?
| | Neuropeptides | 3 | 2018 | 76 | 0.250 |
Why?
| | Periaqueductal Gray | 3 | 2017 | 37 | 0.250 |
Why?
| | Age Factors | 7 | 2021 | 3347 | 0.250 |
Why?
| | Allosteric Site | 1 | 2007 | 18 | 0.250 |
Why?
| | Rats, Inbred F344 | 4 | 2019 | 266 | 0.250 |
Why?
| | Vaccines | 1 | 2012 | 389 | 0.250 |
Why?
| | Receptors, Interleukin-6 | 2 | 2024 | 49 | 0.250 |
Why?
| | Limbic System | 1 | 2007 | 55 | 0.240 |
Why?
| | Restraint, Physical | 4 | 2015 | 70 | 0.240 |
Why?
| | Maze Learning | 6 | 2021 | 106 | 0.240 |
Why?
| | Histamine | 2 | 2006 | 52 | 0.240 |
Why?
| | Up-Regulation | 4 | 2012 | 841 | 0.230 |
Why?
| | 5-Hydroxytryptophan | 5 | 2022 | 19 | 0.230 |
Why?
| | Adult | 25 | 2026 | 41087 | 0.230 |
Why?
| | Indomethacin | 1 | 2006 | 76 | 0.230 |
Why?
| | Biguanides | 1 | 2005 | 10 | 0.230 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2006 | 82 | 0.230 |
Why?
| | Receptors, Serotonin, 5-HT3 | 1 | 2005 | 16 | 0.230 |
Why?
| | Biomarkers | 4 | 2026 | 4340 | 0.230 |
Why?
| | Telemetry | 2 | 2017 | 41 | 0.230 |
Why?
| | Receptors, GABA-A | 1 | 2007 | 138 | 0.230 |
Why?
| | In Situ Hybridization | 5 | 2012 | 317 | 0.230 |
Why?
| | Prolactin | 2 | 2005 | 88 | 0.230 |
Why?
| | Benzodiazepines | 1 | 2007 | 158 | 0.230 |
Why?
| | Hypothalamic Area, Lateral | 1 | 2005 | 3 | 0.220 |
Why?
| | Environmental Microbiology | 2 | 2019 | 46 | 0.220 |
Why?
| | Microdialysis | 6 | 2025 | 56 | 0.210 |
Why?
| | Vimentin | 1 | 2005 | 47 | 0.210 |
Why?
| | Adrenal Medulla | 1 | 2004 | 10 | 0.210 |
Why?
| | Antibodies, Bacterial | 1 | 2025 | 147 | 0.210 |
Why?
| | Onchocerciasis | 2 | 2001 | 8 | 0.210 |
Why?
| | Life Change Events | 1 | 2005 | 144 | 0.210 |
Why?
| | Healthy Aging | 1 | 2024 | 44 | 0.210 |
Why?
| | Criminology | 1 | 2024 | 2 | 0.210 |
Why?
| | Glucans | 1 | 2024 | 22 | 0.200 |
Why?
| | Fibroblast Growth Factor 8 | 2 | 2014 | 26 | 0.200 |
Why?
| | Insect Vectors | 2 | 2001 | 39 | 0.200 |
Why?
| | Dopamine | 3 | 2018 | 295 | 0.200 |
Why?
| | Middle Aged | 17 | 2026 | 36619 | 0.200 |
Why?
| | Progesterone | 2 | 2025 | 214 | 0.200 |
Why?
| | Adjuvants, Pharmaceutic | 1 | 2023 | 15 | 0.200 |
Why?
| | Helicobacter Infections | 2 | 2021 | 30 | 0.200 |
Why?
| | Neuroimmunomodulation | 2 | 2019 | 67 | 0.200 |
Why?
| | Bile Acids and Salts | 2 | 2024 | 163 | 0.200 |
Why?
| | Oligosaccharides | 1 | 2024 | 62 | 0.200 |
Why?
| | Intra-Abdominal Fat | 1 | 2024 | 104 | 0.200 |
Why?
| | Mice, Inbred Strains | 2 | 2023 | 384 | 0.200 |
Why?
| | Specimen Handling | 1 | 2025 | 178 | 0.200 |
Why?
| | Tuberculosis, Bovine | 1 | 2023 | 2 | 0.200 |
Why?
| | Paraventricular Hypothalamic Nucleus | 2 | 2018 | 34 | 0.200 |
Why?
| | Estrogens | 2 | 2025 | 364 | 0.200 |
Why?
| | Diazepam | 1 | 2023 | 32 | 0.200 |
Why?
| | Cerebral Cortex | 1 | 2007 | 485 | 0.190 |
Why?
| | Leptin | 1 | 2024 | 248 | 0.190 |
Why?
| | Macrophages | 2 | 2023 | 1532 | 0.190 |
Why?
| | Dendritic Cells | 1 | 2026 | 509 | 0.180 |
Why?
| | Friends | 1 | 2023 | 57 | 0.180 |
Why?
| | Receptors, Neuropeptide | 2 | 2012 | 6 | 0.180 |
Why?
| | Adjuvants, Immunologic | 1 | 2023 | 245 | 0.180 |
Why?
| | Random Allocation | 4 | 2009 | 366 | 0.180 |
Why?
| | Administration, Oral | 1 | 2025 | 872 | 0.180 |
Why?
| | Mucins | 1 | 2022 | 75 | 0.180 |
Why?
| | Planets | 1 | 2021 | 1 | 0.180 |
Why?
| | Norepinephrine | 5 | 2005 | 201 | 0.170 |
Why?
| | Estradiol | 2 | 2025 | 517 | 0.170 |
Why?
| | Hydrazines | 3 | 2018 | 37 | 0.170 |
Why?
| | Coinfection | 1 | 2023 | 143 | 0.170 |
Why?
| | Serotonin Antagonists | 2 | 2015 | 33 | 0.170 |
Why?
| | Neopterin | 2 | 2022 | 13 | 0.170 |
Why?
| | Hygiene | 2 | 2014 | 29 | 0.170 |
Why?
| | Populus | 1 | 2021 | 15 | 0.170 |
Why?
| | Helicobacter pylori | 1 | 2021 | 44 | 0.170 |
Why?
| | Insect Bites and Stings | 1 | 2001 | 13 | 0.170 |
Why?
| | Piperazines | 3 | 2010 | 368 | 0.170 |
Why?
| | Adrenalectomy | 2 | 2015 | 68 | 0.160 |
Why?
| | Cholera Toxin | 3 | 2013 | 27 | 0.160 |
Why?
| | Groundwater | 1 | 2021 | 40 | 0.160 |
Why?
| | Brain Stem | 3 | 2006 | 101 | 0.160 |
Why?
| | Diptera | 1 | 2001 | 31 | 0.160 |
Why?
| | Carrier Proteins | 1 | 2005 | 728 | 0.160 |
Why?
| | Escape Reaction | 2 | 2017 | 55 | 0.160 |
Why?
| | Epinephrine | 2 | 2005 | 160 | 0.160 |
Why?
| | Temporomandibular Joint | 1 | 2020 | 8 | 0.160 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2025 | 438 | 0.160 |
Why?
| | In Vitro Techniques | 3 | 2009 | 1041 | 0.160 |
Why?
| | Frailty | 1 | 2024 | 208 | 0.160 |
Why?
| | Seasonal Affective Disorder | 1 | 2020 | 9 | 0.150 |
Why?
| | United States | 7 | 2025 | 16136 | 0.150 |
Why?
| | Gain of Function Mutation | 1 | 2020 | 35 | 0.150 |
Why?
| | Shock | 1 | 2021 | 101 | 0.150 |
Why?
| | Adiposity | 1 | 2024 | 533 | 0.150 |
Why?
| | Neuropsychiatry | 1 | 2020 | 17 | 0.150 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2012 | 233 | 0.150 |
Why?
| | Multiple Trauma | 1 | 2021 | 118 | 0.150 |
Why?
| | Receptors, Calcitriol | 1 | 2020 | 54 | 0.150 |
Why?
| | Mycobacterium tuberculosis | 1 | 2023 | 325 | 0.150 |
Why?
| | Autoradiography | 2 | 2009 | 65 | 0.150 |
Why?
| | Urban Population | 2 | 2025 | 497 | 0.150 |
Why?
| | Communicable Diseases | 1 | 2022 | 166 | 0.150 |
Why?
| | Periodontitis | 1 | 2020 | 55 | 0.150 |
Why?
| | Pregnancy Complications | 1 | 2025 | 609 | 0.150 |
Why?
| | Central Amygdaloid Nucleus | 1 | 2019 | 3 | 0.150 |
Why?
| | Mice, 129 Strain | 1 | 2019 | 83 | 0.140 |
Why?
| | Psycholinguistics | 1 | 2019 | 20 | 0.140 |
Why?
| | Individuality | 2 | 2019 | 152 | 0.140 |
Why?
| | Phobic Disorders | 1 | 2019 | 36 | 0.140 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2025 | 665 | 0.140 |
Why?
| | Sleep Disorders, Circadian Rhythm | 1 | 2019 | 55 | 0.140 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2023 | 339 | 0.140 |
Why?
| | Memory, Episodic | 1 | 2019 | 58 | 0.140 |
Why?
| | Animal Assisted Therapy | 1 | 2018 | 12 | 0.140 |
Why?
| | United States Department of Veterans Affairs | 2 | 2024 | 777 | 0.140 |
Why?
| | Hypothalamus, Middle | 2 | 2010 | 2 | 0.140 |
Why?
| | Soil Microbiology | 1 | 2019 | 115 | 0.140 |
Why?
| | Alarmins | 1 | 2018 | 27 | 0.140 |
Why?
| | Yohimbine | 2 | 2010 | 11 | 0.140 |
Why?
| | Housing | 1 | 2019 | 142 | 0.130 |
Why?
| | HMGB1 Protein | 1 | 2018 | 51 | 0.130 |
Why?
| | Biogenic Monoamines | 2 | 2009 | 17 | 0.130 |
Why?
| | Adiponectin | 1 | 2020 | 243 | 0.130 |
Why?
| | Health Promotion | 1 | 2024 | 786 | 0.130 |
Why?
| | Vasopressins | 1 | 1998 | 60 | 0.130 |
Why?
| | MicroRNAs | 2 | 2014 | 699 | 0.130 |
Why?
| | Nervous System | 1 | 1998 | 68 | 0.130 |
Why?
| | Vertebrates | 1 | 1998 | 63 | 0.130 |
Why?
| | Injections, Intraventricular | 2 | 2009 | 60 | 0.130 |
Why?
| | Grooming | 2 | 2009 | 9 | 0.130 |
Why?
| | Nesting Behavior | 1 | 2018 | 17 | 0.130 |
Why?
| | Phenylalanine | 1 | 2018 | 69 | 0.130 |
Why?
| | Trauma and Stressor Related Disorders | 1 | 2017 | 2 | 0.130 |
Why?
| | Mice, Knockout | 4 | 2019 | 3125 | 0.130 |
Why?
| | Cross-Sectional Studies | 3 | 2026 | 5899 | 0.130 |
Why?
| | Amphibians | 1 | 1998 | 55 | 0.130 |
Why?
| | Autism Spectrum Disorder | 2 | 2020 | 406 | 0.130 |
Why?
| | Desipramine | 2 | 2015 | 10 | 0.130 |
Why?
| | Tyrosine | 1 | 2018 | 217 | 0.130 |
Why?
| | Noise | 1 | 2018 | 68 | 0.130 |
Why?
| | Genetic Fitness | 1 | 2018 | 60 | 0.130 |
Why?
| | Food Chain | 1 | 2017 | 37 | 0.130 |
Why?
| | Helicobacter | 1 | 2016 | 3 | 0.130 |
Why?
| | Receptors, Glucocorticoid | 2 | 2017 | 132 | 0.130 |
Why?
| | Songbirds | 1 | 2018 | 46 | 0.120 |
Why?
| | Gliadin | 1 | 2016 | 11 | 0.120 |
Why?
| | Tissue Distribution | 3 | 2006 | 334 | 0.120 |
Why?
| | Pilot Projects | 2 | 2024 | 1888 | 0.120 |
Why?
| | Altitude | 1 | 2021 | 469 | 0.120 |
Why?
| | Hydrocortisone | 2 | 2018 | 303 | 0.120 |
Why?
| | Nerve Tissue Proteins | 2 | 2018 | 597 | 0.120 |
Why?
| | Impulsive Behavior | 1 | 2018 | 146 | 0.120 |
Why?
| | Psychomotor Performance | 1 | 2019 | 329 | 0.120 |
Why?
| | Down-Regulation | 1 | 2018 | 614 | 0.120 |
Why?
| | Species Specificity | 3 | 2023 | 543 | 0.120 |
Why?
| | Global Health | 1 | 2019 | 403 | 0.120 |
Why?
| | Drug Administration Routes | 2 | 2007 | 41 | 0.120 |
Why?
| | Immunity, Cellular | 1 | 2018 | 277 | 0.120 |
Why?
| | Biogenic Amines | 1 | 1996 | 4 | 0.120 |
Why?
| | Video Recording | 2 | 2009 | 219 | 0.120 |
Why?
| | Sick Building Syndrome | 1 | 2015 | 4 | 0.120 |
Why?
| | Obesity | 3 | 2024 | 3131 | 0.120 |
Why?
| | Rectum | 1 | 2017 | 180 | 0.110 |
Why?
| | Young Adult | 7 | 2025 | 14330 | 0.110 |
Why?
| | Adrenal Glands | 2 | 2016 | 77 | 0.110 |
Why?
| | Affect | 1 | 2018 | 318 | 0.110 |
Why?
| | Combined Modality Therapy | 1 | 2018 | 1271 | 0.110 |
Why?
| | Radioimmunoassay | 2 | 2009 | 162 | 0.110 |
Why?
| | Staining and Labeling | 2 | 2006 | 148 | 0.110 |
Why?
| | Epilepsy | 1 | 2020 | 400 | 0.110 |
Why?
| | Lipids | 1 | 2020 | 714 | 0.110 |
Why?
| | Membrane Potentials | 1 | 1996 | 278 | 0.110 |
Why?
| | Leukocytes, Mononuclear | 1 | 2018 | 585 | 0.110 |
Why?
| | Cohort Studies | 3 | 2024 | 6077 | 0.110 |
Why?
| | Receptors, Adrenergic, beta-1 | 1 | 2014 | 24 | 0.110 |
Why?
| | Receptors, Steroid | 1 | 1995 | 41 | 0.110 |
Why?
| | Feedback, Physiological | 1 | 2015 | 79 | 0.110 |
Why?
| | Argonaute Proteins | 1 | 2014 | 32 | 0.110 |
Why?
| | Learning | 1 | 2019 | 446 | 0.110 |
Why?
| | Metabolic Networks and Pathways | 1 | 2015 | 175 | 0.110 |
Why?
| | Extracellular Space | 2 | 2019 | 118 | 0.100 |
Why?
| | Diet | 4 | 2024 | 1273 | 0.100 |
Why?
| | Urbanization | 1 | 2014 | 28 | 0.100 |
Why?
| | Chronic Disease | 2 | 2019 | 1827 | 0.100 |
Why?
| | White Matter | 1 | 2016 | 169 | 0.100 |
Why?
| | Oncogene Proteins v-fos | 1 | 2013 | 5 | 0.100 |
Why?
| | Quality of Life | 2 | 2024 | 3200 | 0.100 |
Why?
| | Proteins | 1 | 2020 | 1022 | 0.100 |
Why?
| | Antidepressive Agents, Tricyclic | 1 | 2013 | 30 | 0.100 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2014 | 59 | 0.100 |
Why?
| | Respiration Disorders | 1 | 2014 | 78 | 0.100 |
Why?
| | Biological Evolution | 2 | 2014 | 471 | 0.100 |
Why?
| | Bradycardia | 2 | 2012 | 63 | 0.100 |
Why?
| | Receptors, Opioid | 2 | 1990 | 21 | 0.100 |
Why?
| | Hypoxia | 1 | 2021 | 1211 | 0.100 |
Why?
| | Seasons | 3 | 2020 | 540 | 0.100 |
Why?
| | Receptors, Angiotensin | 1 | 2013 | 11 | 0.100 |
Why?
| | Comorbidity | 2 | 2017 | 1665 | 0.100 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2021 | 846 | 0.100 |
Why?
| | Alzheimer Disease | 1 | 2020 | 641 | 0.100 |
Why?
| | Sleep | 4 | 2021 | 896 | 0.100 |
Why?
| | Deoxyadenine Nucleotides | 1 | 2013 | 16 | 0.090 |
Why?
| | Skin | 3 | 2023 | 701 | 0.090 |
Why?
| | Emigration and Immigration | 1 | 2014 | 67 | 0.090 |
Why?
| | Body Weight | 1 | 2017 | 968 | 0.090 |
Why?
| | Adrenocorticotropic Hormone | 2 | 2011 | 145 | 0.090 |
Why?
| | Avoidance Learning | 1 | 2013 | 64 | 0.090 |
Why?
| | Rodentia | 1 | 2013 | 63 | 0.090 |
Why?
| | Rural Population | 1 | 2018 | 677 | 0.090 |
Why?
| | Amphetamine | 1 | 2012 | 37 | 0.090 |
Why?
| | Follow-Up Studies | 3 | 2018 | 5439 | 0.090 |
Why?
| | Pregnancy | 6 | 2025 | 7230 | 0.090 |
Why?
| | Serotonin 5-HT1 Receptor Agonists | 1 | 2012 | 3 | 0.090 |
Why?
| | Sodium Lactate | 2 | 2013 | 3 | 0.090 |
Why?
| | Angiotensin II | 1 | 2013 | 102 | 0.090 |
Why?
| | Weaning | 1 | 2012 | 50 | 0.090 |
Why?
| | Cognitive Dysfunction | 1 | 2018 | 481 | 0.090 |
Why?
| | Brain Injuries | 1 | 2017 | 499 | 0.090 |
Why?
| | Resilience, Psychological | 1 | 2014 | 141 | 0.090 |
Why?
| | Phenotype | 3 | 2021 | 3206 | 0.090 |
Why?
| | Metagenomics | 2 | 2024 | 154 | 0.090 |
Why?
| | Homeostasis | 1 | 2015 | 646 | 0.080 |
Why?
| | ATP-Binding Cassette Transporters | 2 | 2002 | 117 | 0.080 |
Why?
| | Hypertension | 2 | 2012 | 1272 | 0.080 |
Why?
| | Memory | 3 | 2018 | 298 | 0.080 |
Why?
| | Cell Line, Transformed | 1 | 2011 | 137 | 0.080 |
Why?
| | Electroshock | 3 | 2017 | 146 | 0.080 |
Why?
| | Feasibility Studies | 2 | 2026 | 1135 | 0.080 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2025 | 2240 | 0.080 |
Why?
| | Aged | 5 | 2024 | 26432 | 0.080 |
Why?
| | Receptors, Adrenergic | 2 | 2006 | 20 | 0.080 |
Why?
| | Neuronal Tract-Tracers | 1 | 2010 | 3 | 0.080 |
Why?
| | Receptor, Serotonin, 5-HT2A | 1 | 2010 | 17 | 0.080 |
Why?
| | Sanitation | 1 | 2010 | 56 | 0.080 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2012 | 185 | 0.080 |
Why?
| | Radiography | 1 | 2013 | 861 | 0.080 |
Why?
| | Gene-Environment Interaction | 1 | 2012 | 190 | 0.080 |
Why?
| | Cell Lineage | 1 | 2012 | 377 | 0.080 |
Why?
| | Injections, Intraperitoneal | 2 | 2009 | 115 | 0.080 |
Why?
| | Environmental Exposure | 1 | 2014 | 578 | 0.070 |
Why?
| | Catheters, Indwelling | 1 | 2010 | 94 | 0.070 |
Why?
| | Social Dominance | 1 | 2009 | 16 | 0.070 |
Why?
| | Tyrosine 3-Monooxygenase | 2 | 2007 | 72 | 0.070 |
Why?
| | Green Fluorescent Proteins | 1 | 2011 | 408 | 0.070 |
Why?
| | Aromatic Amino Acid Decarboxylase Inhibitors | 1 | 2009 | 1 | 0.070 |
Why?
| | Feeding Behavior | 2 | 2006 | 692 | 0.070 |
Why?
| | Thermosensing | 1 | 2008 | 12 | 0.070 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 457 | 0.070 |
Why?
| | Amino Acid Sequence | 2 | 2011 | 2092 | 0.070 |
Why?
| | HIV Infections | 1 | 2024 | 3215 | 0.070 |
Why?
| | Risk Factors | 4 | 2026 | 10921 | 0.070 |
Why?
| | Transfection | 1 | 2011 | 916 | 0.070 |
Why?
| | Pargyline | 1 | 2008 | 3 | 0.070 |
Why?
| | Neuropsychological Tests | 2 | 2020 | 1149 | 0.070 |
Why?
| | N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2008 | 11 | 0.070 |
Why?
| | Mice, Transgenic | 4 | 2014 | 2134 | 0.070 |
Why?
| | Seroepidemiologic Studies | 2 | 2019 | 171 | 0.070 |
Why?
| | Temperature | 1 | 2011 | 635 | 0.070 |
Why?
| | Biological Transport | 2 | 2006 | 424 | 0.070 |
Why?
| | T-Lymphocyte Subsets | 1 | 2010 | 416 | 0.070 |
Why?
| | Immune Tolerance | 1 | 2010 | 386 | 0.070 |
Why?
| | Pyridines | 2 | 2013 | 610 | 0.070 |
Why?
| | Central Nervous System Stimulants | 2 | 2012 | 183 | 0.070 |
Why?
| | Somatoform Disorders | 1 | 2007 | 34 | 0.070 |
Why?
| | Acoustic Stimulation | 1 | 2009 | 325 | 0.060 |
Why?
| | Self Report | 2 | 2024 | 870 | 0.060 |
Why?
| | Statistics as Topic | 1 | 2008 | 279 | 0.060 |
Why?
| | Bronchopulmonary Sequestration | 1 | 2007 | 9 | 0.060 |
Why?
| | Exercise | 2 | 2024 | 2213 | 0.060 |
Why?
| | Tryptamines | 1 | 2006 | 5 | 0.060 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2007 | 141 | 0.060 |
Why?
| | Evidence-Based Medicine | 1 | 2010 | 731 | 0.060 |
Why?
| | Darkness | 1 | 2006 | 26 | 0.060 |
Why?
| | Synapses | 1 | 2010 | 448 | 0.060 |
Why?
| | Tegmentum Mesencephali | 1 | 2006 | 5 | 0.060 |
Why?
| | Genotype | 3 | 2020 | 1879 | 0.060 |
Why?
| | Heart Rate | 2 | 2025 | 846 | 0.060 |
Why?
| | Tissue Fixation | 1 | 2005 | 35 | 0.060 |
Why?
| | Peptide Fragments | 2 | 2008 | 693 | 0.060 |
Why?
| | Cell Membrane | 2 | 2022 | 701 | 0.060 |
Why?
| | Chromatography, Liquid | 2 | 2021 | 453 | 0.060 |
Why?
| | Drug Interactions | 1 | 2007 | 405 | 0.060 |
Why?
| | Longitudinal Studies | 2 | 2026 | 3017 | 0.060 |
Why?
| | Genome-Wide Association Study | 2 | 2025 | 1537 | 0.060 |
Why?
| | Serogroup | 1 | 2025 | 46 | 0.060 |
Why?
| | Median Eminence | 1 | 2005 | 5 | 0.060 |
Why?
| | Arcuate Nucleus of Hypothalamus | 1 | 2005 | 12 | 0.060 |
Why?
| | Stilbamidines | 1 | 2005 | 9 | 0.050 |
Why?
| | Blood Pressure | 2 | 2013 | 1765 | 0.050 |
Why?
| | Adrenergic alpha-Antagonists | 1 | 2005 | 34 | 0.050 |
Why?
| | Injections | 1 | 2005 | 201 | 0.050 |
Why?
| | Blood-Brain Barrier | 1 | 2006 | 169 | 0.050 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2009 | 778 | 0.050 |
Why?
| | Heart Atria | 1 | 2005 | 139 | 0.050 |
Why?
| | Autoimmunity | 1 | 2010 | 925 | 0.050 |
Why?
| | Microinjections | 2 | 2015 | 92 | 0.050 |
Why?
| | Neurons, Efferent | 1 | 2004 | 9 | 0.050 |
Why?
| | Mind-Body Therapies | 1 | 2024 | 9 | 0.050 |
Why?
| | Nerve Fibers | 1 | 2005 | 105 | 0.050 |
Why?
| | Genes, Immediate-Early | 1 | 2004 | 25 | 0.050 |
Why?
| | Lomustine | 1 | 2024 | 18 | 0.050 |
Why?
| | Sympathetic Nervous System | 1 | 2005 | 177 | 0.050 |
Why?
| | Ovariectomy | 1 | 2025 | 164 | 0.050 |
Why?
| | Colorado | 2 | 2024 | 4595 | 0.050 |
Why?
| | Brazil | 2 | 2001 | 179 | 0.050 |
Why?
| | Mouth | 1 | 2024 | 84 | 0.050 |
Why?
| | Metagenome | 1 | 2024 | 127 | 0.050 |
Why?
| | Perfusion | 1 | 2005 | 255 | 0.050 |
Why?
| | Crime | 1 | 2024 | 58 | 0.050 |
Why?
| | Criminal Law | 1 | 2024 | 31 | 0.050 |
Why?
| | Reproducibility of Results | 2 | 2024 | 3416 | 0.050 |
Why?
| | Spleen | 1 | 2025 | 503 | 0.050 |
Why?
| | Action Potentials | 2 | 2011 | 500 | 0.050 |
Why?
| | Saliva | 1 | 2025 | 256 | 0.050 |
Why?
| | Rats, Inbred Lew | 1 | 2003 | 105 | 0.050 |
Why?
| | Drosophila Proteins | 2 | 2002 | 207 | 0.050 |
Why?
| | Prednisone | 1 | 2024 | 229 | 0.050 |
Why?
| | Psychiatric Status Rating Scales | 2 | 2016 | 522 | 0.050 |
Why?
| | Immunoglobulin M | 1 | 2024 | 284 | 0.050 |
Why?
| | Orexin Receptors | 2 | 2012 | 4 | 0.050 |
Why?
| | Carbidopa | 1 | 2022 | 10 | 0.050 |
Why?
| | Psychoneuroimmunology | 1 | 2022 | 9 | 0.050 |
Why?
| | Neurodegenerative Diseases | 1 | 2024 | 147 | 0.050 |
Why?
| | Blotting, Western | 1 | 2005 | 1177 | 0.040 |
Why?
| | Fever | 1 | 2024 | 322 | 0.040 |
Why?
| | Fathers | 1 | 2022 | 53 | 0.040 |
Why?
| | Models, Biological | 2 | 2007 | 1761 | 0.040 |
Why?
| | Blood Glucose | 2 | 2011 | 2360 | 0.040 |
Why?
| | Bacteroidetes | 1 | 2021 | 20 | 0.040 |
Why?
| | Simuliidae | 1 | 2001 | 1 | 0.040 |
Why?
| | Polysomnography | 2 | 2019 | 239 | 0.040 |
Why?
| | Nontuberculous Mycobacteria | 1 | 2023 | 189 | 0.040 |
Why?
| | Eye | 1 | 2002 | 112 | 0.040 |
Why?
| | Counseling | 1 | 2024 | 406 | 0.040 |
Why?
| | Anhedonia | 1 | 2021 | 18 | 0.040 |
Why?
| | Endophenotypes | 1 | 2021 | 37 | 0.040 |
Why?
| | Biodegradation, Environmental | 1 | 2021 | 74 | 0.040 |
Why?
| | Trees | 1 | 2021 | 61 | 0.040 |
Why?
| | Supervised Machine Learning | 1 | 2021 | 23 | 0.040 |
Why?
| | Granulocytes | 1 | 2021 | 82 | 0.040 |
Why?
| | Microfilament Proteins | 1 | 2022 | 136 | 0.040 |
Why?
| | Social Justice | 1 | 2022 | 83 | 0.040 |
Why?
| | Dietary Sucrose | 1 | 2021 | 49 | 0.040 |
Why?
| | Rivers | 1 | 2021 | 62 | 0.040 |
Why?
| | Linkage Disequilibrium | 1 | 2001 | 260 | 0.040 |
Why?
| | Cattle | 1 | 2023 | 940 | 0.040 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 1 | 2021 | 224 | 0.040 |
Why?
| | Dreams | 1 | 2000 | 15 | 0.040 |
Why?
| | Toll-Like Receptor 4 | 1 | 2023 | 277 | 0.040 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2024 | 539 | 0.040 |
Why?
| | Policy | 1 | 2022 | 147 | 0.040 |
Why?
| | Cations | 1 | 2021 | 83 | 0.040 |
Why?
| | Microelectrodes | 1 | 2000 | 49 | 0.040 |
Why?
| | Calcium-Binding Proteins | 1 | 2022 | 221 | 0.040 |
Why?
| | Choice Behavior | 1 | 2022 | 179 | 0.040 |
Why?
| | Asthma | 1 | 2012 | 1800 | 0.040 |
Why?
| | Program Evaluation | 1 | 2024 | 952 | 0.040 |
Why?
| | Benzomorphans | 2 | 1990 | 2 | 0.040 |
Why?
| | Social Support | 1 | 2024 | 646 | 0.040 |
Why?
| | Population Dynamics | 1 | 2001 | 142 | 0.040 |
Why?
| | Cathelicidins | 1 | 2020 | 40 | 0.040 |
Why?
| | DNA, Ribosomal | 1 | 2020 | 83 | 0.040 |
Why?
| | Positive-Pressure Respiration | 1 | 2000 | 115 | 0.040 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2020 | 81 | 0.040 |
Why?
| | Sleep Apnea Syndromes | 1 | 2000 | 98 | 0.040 |
Why?
| | Chromosome Mapping | 1 | 2020 | 508 | 0.040 |
Why?
| | Normetanephrine | 1 | 2019 | 4 | 0.040 |
Why?
| | Social Environment | 2 | 2010 | 246 | 0.040 |
Why?
| | Lymphocytes | 1 | 2021 | 379 | 0.040 |
Why?
| | Dextran Sulfate | 1 | 2019 | 93 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2024 | 2070 | 0.040 |
Why?
| | Administration, Intranasal | 1 | 2019 | 95 | 0.040 |
Why?
| | ROC Curve | 1 | 2021 | 617 | 0.040 |
Why?
| | Interpersonal Relations | 2 | 2015 | 387 | 0.040 |
Why?
| | Photic Stimulation | 1 | 2020 | 265 | 0.040 |
Why?
| | Axons | 1 | 2000 | 205 | 0.040 |
Why?
| | Optogenetics | 1 | 2020 | 103 | 0.040 |
Why?
| | Reaction Time | 1 | 2000 | 438 | 0.030 |
Why?
| | Patient-Centered Care | 1 | 2024 | 553 | 0.030 |
Why?
| | Bipolar Disorder | 1 | 2001 | 285 | 0.030 |
Why?
| | Genetic Testing | 1 | 2001 | 492 | 0.030 |
Why?
| | Biodiversity | 1 | 2021 | 314 | 0.030 |
Why?
| | Quantitative Trait Loci | 1 | 2020 | 388 | 0.030 |
Why?
| | Serologic Tests | 1 | 2018 | 50 | 0.030 |
Why?
| | Extracellular Fluid | 2 | 2010 | 38 | 0.030 |
Why?
| | Task Performance and Analysis | 1 | 2019 | 203 | 0.030 |
Why?
| | Patient Care Team | 1 | 2024 | 701 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2021 | 576 | 0.030 |
Why?
| | Agoraphobia | 1 | 2017 | 9 | 0.030 |
Why?
| | Wakefulness | 1 | 2019 | 170 | 0.030 |
Why?
| | Feathers | 1 | 2018 | 38 | 0.030 |
Why?
| | Metabolome | 1 | 2021 | 390 | 0.030 |
Why?
| | Germany | 1 | 2018 | 139 | 0.030 |
Why?
| | Nucleic Acid Probes | 1 | 1997 | 2 | 0.030 |
Why?
| | Electroencephalography | 1 | 2021 | 576 | 0.030 |
Why?
| | Ethylmaleimide | 1 | 1997 | 18 | 0.030 |
Why?
| | Thionucleotides | 1 | 1997 | 35 | 0.030 |
Why?
| | Inhibitory Postsynaptic Potentials | 1 | 2017 | 47 | 0.030 |
Why?
| | Body Size | 1 | 2018 | 91 | 0.030 |
Why?
| | Healthy Volunteers | 1 | 2018 | 218 | 0.030 |
Why?
| | Picrotoxin | 1 | 2017 | 12 | 0.030 |
Why?
| | Oxytocin | 1 | 1997 | 51 | 0.030 |
Why?
| | Dogs | 1 | 2018 | 517 | 0.030 |
Why?
| | Nerve Net | 1 | 2020 | 286 | 0.030 |
Why?
| | Quinolines | 2 | 2010 | 191 | 0.030 |
Why?
| | Arizona | 1 | 2016 | 81 | 0.030 |
Why?
| | Anisotropy | 1 | 2016 | 77 | 0.030 |
Why?
| | 5,7-Dihydroxytryptamine | 1 | 2015 | 2 | 0.030 |
Why?
| | Adrenergic Uptake Inhibitors | 1 | 2015 | 14 | 0.030 |
Why?
| | Diffusion Tensor Imaging | 1 | 2016 | 83 | 0.030 |
Why?
| | Organ Size | 1 | 2016 | 465 | 0.030 |
Why?
| | Thymus Gland | 1 | 2016 | 310 | 0.030 |
Why?
| | Attention | 1 | 2019 | 463 | 0.030 |
Why?
| | Computational Biology | 1 | 2020 | 678 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2024 | 11821 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2020 | 516 | 0.030 |
Why?
| | Rabbits | 1 | 2016 | 651 | 0.030 |
Why?
| | Environment | 1 | 2017 | 299 | 0.030 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2014 | 10 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 853 | 0.030 |
Why?
| | Mifepristone | 1 | 2014 | 45 | 0.030 |
Why?
| | Freezing Reaction, Cataleptic | 1 | 2014 | 27 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 2018 | 823 | 0.030 |
Why?
| | Mice, Inbred ICR | 1 | 2014 | 103 | 0.030 |
Why?
| | Executive Function | 1 | 2019 | 463 | 0.030 |
Why?
| | Calcium | 1 | 2000 | 1181 | 0.030 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2018 | 352 | 0.030 |
Why?
| | Electrochemical Techniques | 1 | 2014 | 55 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2016 | 255 | 0.030 |
Why?
| | Self-Injurious Behavior | 1 | 2015 | 129 | 0.030 |
Why?
| | Catalysis | 1 | 2014 | 304 | 0.030 |
Why?
| | Immune System Diseases | 1 | 2014 | 43 | 0.020 |
Why?
| | Receptors, Opioid, kappa | 2 | 1990 | 9 | 0.020 |
Why?
| | Memory Disorders | 1 | 2014 | 198 | 0.020 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2016 | 627 | 0.020 |
Why?
| | Heterozygote | 1 | 2014 | 311 | 0.020 |
Why?
| | Angiotensin II Type 2 Receptor Blockers | 1 | 2013 | 7 | 0.020 |
Why?
| | Mothers | 1 | 1999 | 772 | 0.020 |
Why?
| | Cues | 1 | 2015 | 326 | 0.020 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 1 | 2013 | 39 | 0.020 |
Why?
| | Pandemics | 1 | 2021 | 1707 | 0.020 |
Why?
| | Adaptation, Physiological | 2 | 2009 | 568 | 0.020 |
Why?
| | Odds Ratio | 1 | 2015 | 1077 | 0.020 |
Why?
| | Prospective Studies | 1 | 2025 | 8123 | 0.020 |
Why?
| | Orexins | 1 | 2012 | 6 | 0.020 |
Why?
| | Androgens | 1 | 1994 | 179 | 0.020 |
Why?
| | Naphthyridines | 1 | 2012 | 20 | 0.020 |
Why?
| | Benzoxazoles | 1 | 2012 | 20 | 0.020 |
Why?
| | Naloxone | 2 | 1990 | 139 | 0.020 |
Why?
| | Sex Factors | 1 | 2018 | 2107 | 0.020 |
Why?
| | Eye Proteins | 2 | 2002 | 93 | 0.020 |
Why?
| | Imidazoles | 1 | 2013 | 245 | 0.020 |
Why?
| | Urea | 1 | 2012 | 84 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 334 | 0.020 |
Why?
| | Respiration | 1 | 2012 | 208 | 0.020 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2010 | 58 | 0.020 |
Why?
| | Fetal Development | 1 | 2014 | 297 | 0.020 |
Why?
| | Muscle Strength | 1 | 2014 | 340 | 0.020 |
Why?
| | Morphinans | 1 | 1989 | 8 | 0.020 |
Why?
| | Receptors, Opioid, mu | 1 | 1990 | 68 | 0.020 |
Why?
| | Organic Chemicals | 1 | 2010 | 113 | 0.020 |
Why?
| | Morphine | 1 | 1990 | 171 | 0.020 |
Why?
| | Allylglycine | 1 | 2007 | 1 | 0.020 |
Why?
| | Choline O-Acetyltransferase | 1 | 2007 | 26 | 0.020 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2007 | 26 | 0.020 |
Why?
| | Mass Screening | 1 | 2016 | 1307 | 0.020 |
Why?
| | Electric Stimulation | 1 | 2008 | 273 | 0.020 |
Why?
| | Pain | 1 | 2013 | 790 | 0.020 |
Why?
| | Glutamate Decarboxylase | 1 | 2007 | 166 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2014 | 4118 | 0.020 |
Why?
| | Pyrroles | 1 | 2008 | 222 | 0.020 |
Why?
| | Autonomic Nervous System | 1 | 2007 | 82 | 0.020 |
Why?
| | Child | 2 | 2019 | 22693 | 0.020 |
Why?
| | 1-Methyl-4-phenylpyridinium | 1 | 2006 | 5 | 0.020 |
Why?
| | Cimetidine | 1 | 1986 | 12 | 0.010 |
Why?
| | Ranitidine | 1 | 1986 | 14 | 0.010 |
Why?
| | Neural Inhibition | 1 | 2007 | 186 | 0.010 |
Why?
| | Growth Hormone | 1 | 1986 | 91 | 0.010 |
Why?
| | Testis | 1 | 1986 | 158 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2005 | 426 | 0.010 |
Why?
| | Pyrimidines | 1 | 2008 | 532 | 0.010 |
Why?
| | Adolescent | 1 | 2024 | 22557 | 0.010 |
Why?
| | Inspiratory Capacity | 1 | 2004 | 3 | 0.010 |
Why?
| | Single-Blind Method | 1 | 2004 | 313 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2012 | 2488 | 0.010 |
Why?
| | Mutation | 1 | 2014 | 4093 | 0.010 |
Why?
| | Reference Values | 1 | 2004 | 796 | 0.010 |
Why?
| | 5' Flanking Region | 1 | 2001 | 9 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2002 | 382 | 0.010 |
Why?
| | Insect Proteins | 1 | 2001 | 38 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2001 | 269 | 0.010 |
Why?
| | 3' Untranslated Regions | 1 | 2001 | 152 | 0.010 |
Why?
| | Microsatellite Repeats | 1 | 2001 | 159 | 0.010 |
Why?
| | Periodicity | 1 | 2000 | 57 | 0.010 |
Why?
| | DNA Primers | 1 | 2001 | 487 | 0.010 |
Why?
| | Introns | 1 | 2001 | 257 | 0.010 |
Why?
| | Exons | 1 | 2001 | 361 | 0.010 |
Why?
| | Drosophila | 1 | 2001 | 168 | 0.010 |
Why?
| | Atrophy | 1 | 1999 | 199 | 0.010 |
Why?
| | Pyramidal Cells | 1 | 1999 | 80 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2017 | 17438 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2002 | 2838 | 0.010 |
Why?
| | RNA, Complementary | 1 | 1997 | 3 | 0.010 |
Why?
| | Sulfur Radioisotopes | 1 | 1997 | 11 | 0.010 |
Why?
| | Thyrotropin-Releasing Hormone | 1 | 1997 | 11 | 0.010 |
Why?
| | Oligonucleotide Probes | 1 | 1997 | 48 | 0.010 |
Why?
| | Neuronal Plasticity | 1 | 1999 | 312 | 0.010 |
Why?
| | Body Mass Index | 1 | 2000 | 2458 | 0.010 |
Why?
| | Testosterone | 1 | 1994 | 419 | 0.000 |
Why?
| | Surveys and Questionnaires | 1 | 2000 | 6073 | 0.000 |
Why?
| | Dyspepsia | 1 | 1986 | 11 | 0.000 |
Why?
| | Glucose Tolerance Test | 1 | 1986 | 360 | 0.000 |
Why?
| | Gonadal Steroid Hormones | 1 | 1986 | 143 | 0.000 |
Why?
| | Insulin | 1 | 1986 | 2525 | 0.000 |
Why?
|
|
Lowry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|